Fibrinogen beta chain: Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS (v470))
m (Adding 0 arxiv eprint(s), 3 bibcode(s) and 0 doi(s). Did it miss something? Report bugs, errors, and suggestions at User talk:Bibcode Bot)
Line 24: Line 24:
*{{cite journal  |vauthors=Vasse M, Paysant J, Soria J |title=Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk. |journal=Haemostasis |volume=26 Suppl 4 |issue=  |pages= 331–9 |year= 1997 |pmid= 8979138 |doi=  10.1159/000217313|display-authors=etal}}
*{{cite journal  |vauthors=Vasse M, Paysant J, Soria J |title=Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk. |journal=Haemostasis |volume=26 Suppl 4 |issue=  |pages= 331–9 |year= 1997 |pmid= 8979138 |doi=  10.1159/000217313|display-authors=etal}}
*{{cite journal  |vauthors=Herrick S, Blanc-Brude O, Gray A, Laurent G |title=Fibrinogen. |journal=Int. J. Biochem. Cell Biol. |volume=31 |issue= 7 |pages= 741–6 |year= 1999 |pmid= 10467729 |doi=10.1016/S1357-2725(99)00032-1  }}
*{{cite journal  |vauthors=Herrick S, Blanc-Brude O, Gray A, Laurent G |title=Fibrinogen. |journal=Int. J. Biochem. Cell Biol. |volume=31 |issue= 7 |pages= 741–6 |year= 1999 |pmid= 10467729 |doi=10.1016/S1357-2725(99)00032-1  }}
*{{cite journal  |vauthors=Redman CM, Xia H |title=Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. |journal=Ann. N. Y. Acad. Sci. |volume=936 |issue=  |pages= 480–95 |year= 2001 |pmid= 11460506 |doi=10.1111/j.1749-6632.2001.tb03535.x  }}
*{{cite journal  |vauthors=Redman CM, Xia H |title=Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. |journal=Ann. N. Y. Acad. Sci. |volume=936 |issue=  |pages= 480–95 |year= 2001 |pmid= 11460506 |doi=10.1111/j.1749-6632.2001.tb03535.x  |bibcode=2001NYASA.936..480R }}
*{{cite journal  |vauthors=Brennan SO, Fellowes AP, George PM |title=Molecular mechanisms of hypo- and afibrinogenemia. |journal=Ann. N. Y. Acad. Sci. |volume=936 |issue=  |pages= 91–100 |year= 2001 |pmid= 11460528 |doi=10.1111/j.1749-6632.2001.tb03496.x  }}
*{{cite journal  |vauthors=Brennan SO, Fellowes AP, George PM |title=Molecular mechanisms of hypo- and afibrinogenemia. |journal=Ann. N. Y. Acad. Sci. |volume=936 |issue=  |pages= 91–100 |year= 2001 |pmid= 11460528 |doi=10.1111/j.1749-6632.2001.tb03496.x  |bibcode=2001NYASA.936...91B }}
*{{cite journal  | author=Everse SJ |title=New insights into fibrin (ogen) structure and function. |journal=Vox Sang. |volume=83 Suppl 1 |issue=  |pages= 375–82 |year= 2003 |pmid= 12617173 |doi=  10.1111/j.1423-0410.2002.tb05338.x}}
*{{cite journal  | author=Everse SJ |title=New insights into fibrin (ogen) structure and function. |journal=Vox Sang. |volume=83 Suppl 1 |issue=  |pages= 375–82 |year= 2003 |pmid= 12617173 |doi=  10.1111/j.1423-0410.2002.tb05338.x}}
*{{cite journal  |vauthors=Scott EM, Ariëns RA, Grant PJ |title=Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. |journal=Arterioscler. Thromb. Vasc. Biol. |volume=24 |issue= 9 |pages= 1558–66 |year= 2005 |pmid= 15217804 |doi= 10.1161/01.ATV.0000136649.83297.bf }}
*{{cite journal  |vauthors=Scott EM, Ariëns RA, Grant PJ |title=Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. |journal=Arterioscler. Thromb. Vasc. Biol. |volume=24 |issue= 9 |pages= 1558–66 |year= 2005 |pmid= 15217804 |doi= 10.1161/01.ATV.0000136649.83297.bf }}
Line 34: Line 34:
*{{cite journal  |vauthors=Gårdlund B, Hessel B, Marguerie G |title=Primary structure of human fibrinogen. Characterization of disulfide-containing cyanogen-bromide fragments. |journal=Eur. J. Biochem. |volume=77 |issue= 3 |pages= 595–610 |year= 1977 |pmid= 891553 |doi=10.1111/j.1432-1033.1977.tb11704.x  |display-authors=etal}}
*{{cite journal  |vauthors=Gårdlund B, Hessel B, Marguerie G |title=Primary structure of human fibrinogen. Characterization of disulfide-containing cyanogen-bromide fragments. |journal=Eur. J. Biochem. |volume=77 |issue= 3 |pages= 595–610 |year= 1977 |pmid= 891553 |doi=10.1111/j.1432-1033.1977.tb11704.x  |display-authors=etal}}
*{{cite journal  |vauthors=Blombäck B, Hessel B, Hogg D |title=Disulfide bridges in nh2 -terminal part of human fibrinogen. |journal=Thromb. Res. |volume=8 |issue= 5 |pages= 639–58 |year= 1976 |pmid= 936108 |doi=10.1016/0049-3848(76)90245-0  }}
*{{cite journal  |vauthors=Blombäck B, Hessel B, Hogg D |title=Disulfide bridges in nh2 -terminal part of human fibrinogen. |journal=Thromb. Res. |volume=8 |issue= 5 |pages= 639–58 |year= 1976 |pmid= 936108 |doi=10.1016/0049-3848(76)90245-0  }}
*{{cite journal  |vauthors=Koopman J, Haverkate F, Grimbergen J |title=Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=89 |issue= 8 |pages= 3478–82 |year= 1992 |pmid= 1565641 |doi=  10.1073/pnas.89.8.3478| pmc=48891  |display-authors=etal}}
*{{cite journal  |vauthors=Koopman J, Haverkate F, Grimbergen J |title=Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=89 |issue= 8 |pages= 3478–82 |year= 1992 |pmid= 1565641 |doi=  10.1073/pnas.89.8.3478| pmc=48891  |display-authors=etal|bibcode=1992PNAS...89.3478K}}
*{{cite journal  |vauthors=Koopman J, Haverkate F, Lord ST |title=Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr. |journal=J. Clin. Invest. |volume=90 |issue= 1 |pages= 238–44 |year= 1992 |pmid= 1634610 |doi=10.1172/JCI115841  | pmc=443086  |display-authors=etal}}
*{{cite journal  |vauthors=Koopman J, Haverkate F, Lord ST |title=Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr. |journal=J. Clin. Invest. |volume=90 |issue= 1 |pages= 238–44 |year= 1992 |pmid= 1634610 |doi=10.1172/JCI115841  | pmc=443086  |display-authors=etal}}
*{{cite journal  |vauthors=Wu C, Chung AE |title=Potential role of entactin in hemostasis. Specific interaction of entactin with fibrinogen A alpha and B beta chains. |journal=J. Biol. Chem. |volume=266 |issue= 28 |pages= 18802–7 |year= 1991 |pmid= 1680863 |doi=  }}
*{{cite journal  |vauthors=Wu C, Chung AE |title=Potential role of entactin in hemostasis. Specific interaction of entactin with fibrinogen A alpha and B beta chains. |journal=J. Biol. Chem. |volume=266 |issue= 28 |pages= 18802–7 |year= 1991 |pmid= 1680863 |doi=  }}

Revision as of 14:30, 23 June 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Fibrinogen beta chain, also known as FGB, is a gene found in humans and most other vertebrates with a similar system of blood coagulation.

The protein encoded by this gene is the beta component of fibrinogen, a blood-borne glycoprotein composed of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency.[1]

Interactions

Fibrinogen beta chain has been shown to interact with Lipoprotein(a).[2]

See also

References

  1. "Entrez Gene: FGB fibrinogen beta chain".
  2. Klose, R; Fresser F; Kochl S; Parson W; Kapetanopoulos A; Fruchart-Najib J; Baier G; Utermann G (December 2000). "Mapping of a minimal apolipoprotein(a) interaction motif conserved in fibrin(ogen) beta - and gamma -chains". J. Biol. Chem. UNITED STATES. 275 (49): 38206–12. doi:10.1074/jbc.M003640200. ISSN 0021-9258. PMID 10980194.

Further reading